← SynDRA
PIRBUTEROL
SynDRA canonical compound SYN0021756 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
| Approval status | Approved · OTC |
| Primary target(s) | ADRB1 | ADRB2 |
| Mechanism of action | adrenergic receptor agonist |
| Indication | bronchospasm |
| Disease area | pulmonary |
All known targets
Mechanisms of action (all sources)
- ADRB2 AGONIST
- Beta-2 adrenergic receptor agonist
- adrenergic receptor agonist
Drug classes
- Adrenergic beta2-Agonists
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic beta-2 Receptor Agonists
- Adrenergic beta-Agonists
- Anti-Asthmatic Agents
- Bronchodilator Agents
- Cardiotonic Agents
- Cardiovascular Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Protective Agents
ATC classes
- R03C · ADRENERGICS FOR SYSTEMIC USE
- R03A · ADRENERGICS, INHALANTS
Cross-references
Synonyms
- (+/-)-Pirbuterol
- pirbuterol acetate
- pirbuterol hydrochloride
- pirbuterol HCl
- ARA-211
- Maxair
- Pirbuterolum
- Pyrbuterol
- Pirbuterol acetate salt
- CP-24315-1
- Maxair (TN)
- Pirbuterol (INN)
- Pirbuterol [INN:BAN]
- Pirbuterolum [INN-Latin]
- CP-24,314-1
- CP-24,314-14
- 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-tert-butylamino ethyl)pyridine, dihydrochloride
- 2-tert-Butylamino-1-(5-hydroxy-6-hydroxymethyl-2-pyridyl)ethanol
- 6-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)-3-pyridinol
- 6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
- OG645J8RVW
- pyrbuterol
- pirbuterolo
- (+-)-Pirbuterol
- RefChem:863636
- DTXCID8026937
- R03CC07
- PIRBUTEROL [INN]
- (+/-)-Pirbuterol; ARA 211
- NSC355078
- UNII-OG645J8RVW
- PIRBUTEROL [MI]
- PIRBUTEROL [VANDF]
- PIRBUTEROL [MART.]
- SCHEMBL4819
- PIRBUTEROL [WHO-DD]
- ()-Pirbuterol; ARA 211
- CHEBI:8245
Look up PIRBUTEROL in the interactive SynDRA portal →